| pubmed-article:20155339 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20155339 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:20155339 | lifeskim:mentions | umls-concept:C0026986 | lld:lifeskim |
| pubmed-article:20155339 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
| pubmed-article:20155339 | lifeskim:mentions | umls-concept:C1514893 | lld:lifeskim |
| pubmed-article:20155339 | lifeskim:mentions | umls-concept:C2699488 | lld:lifeskim |
| pubmed-article:20155339 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20155339 | pubmed:dateCreated | 2010-4-5 | lld:pubmed |
| pubmed-article:20155339 | pubmed:abstractText | Although great advancements have been witnessed in treatment results for hematopoietic tumors in recent years, development of secondary malignant tumors induced by anti-cancer drugs still remains a serious issue. We experienced a case of secondary myelodysplastic syndrome (MDS), possibly induced by cyclophosphamide (CY), which was spontaneously resolved by discontinuance of CY. A 24-year-old woman was diagnosed with follicular lymphoma in January 1998: she had developed bulky intra-abdominal lymphadenopathy, with repeated relapse and remission by several chemotherapy treatments. Remission was induced by rituximab, administered at the time of relapse in 2001, followed by administration of 50 mg/day of CY since December 2001 for the prevention of relapse. Anemia and thrombocytopenia developed around January 2003. Bone marrow aspiration revealed abnormality in two lineages and a complicated chromosomal anomaly, and the patient was diagnosed with MDS. Discontinuance of CY and administration of an anabolic steroid improved anemia and thrombocytopenia within 2 years. Bone marrow aspiration in 2006 showed improvement in morphological abnormality and disappearance of chromosomal abnormality. | lld:pubmed |
| pubmed-article:20155339 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20155339 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20155339 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20155339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20155339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20155339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20155339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20155339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20155339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20155339 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20155339 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:20155339 | pubmed:issn | 1865-3774 | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:YamazakiTetsu... | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:MiuraKatsuhir... | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:HattaYoshihir... | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:SawadaUmihiko... | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:TakeuchiJinJ | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:KuraYoshimasa... | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:TakeiKazuhiro... | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:IshizukaHikar... | lld:pubmed |
| pubmed-article:20155339 | pubmed:author | pubmed-author:NakagawaYoshi... | lld:pubmed |
| pubmed-article:20155339 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20155339 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:20155339 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20155339 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20155339 | pubmed:pagination | 530-3 | lld:pubmed |
| pubmed-article:20155339 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:meshHeading | pubmed-meshheading:20155339... | lld:pubmed |
| pubmed-article:20155339 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20155339 | pubmed:articleTitle | A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance. | lld:pubmed |
| pubmed-article:20155339 | pubmed:affiliation | Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi Ward, Tokyo, Japan. | lld:pubmed |
| pubmed-article:20155339 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20155339 | pubmed:publicationType | Case Reports | lld:pubmed |
